Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
XB-PHENO-25521
Ossipova O et al. (2020)
|
Xla Wt + pnhd + animal cap explant
NF12 (RT-PCR)
|
|
|
|
Fig.5.F
Ossipova O et al. (2020)
|
Xla Wt + pnhd MO + marginal zone explant
NF10.5 (RT-PCR)
|
|
|
|
Fig.S4.F
Ossipova O et al. (2020)
|
Xla Wt + pnhd MO + marginal zone explant
NF10.5 (RT-PCR)
|
|
|
|
Fig.6.C
Ossipova O et al. (2020)
|
Xla Wt + wnt8a + animal cap explant
NF12 (RT-PCR)
|
|
|
|
Fig.3.D,E
Ossipova O et al. (2020)
|
Xla Wt + Xla.pnhd-FLAG + animal cap explant
NF12 (RT-PCR)
|
|
|
|
Fig. 3.B
Popov IK et al. (2019)
|
Xla. Hsa.DN-FGFR1
NF10.5 (in situ hybridization)
|
|
|
|
Fig. 5 L
Sempou E et al. (2018)
|
Xtr Wt + fgfr4 CRISPR
NF12 (in situ hybridization)
|
|
congenital heart disease
visceral heterotaxy
|
|
Fig 10 D^1
Hooker LN et al. (2017)
|
Xla Wt + pitx3 MO
NF10.5 (in situ hybridization)
|
|
|
|
S2 A
Reid CD et al. (2016)
|
Xla Wt + nodal1
gastrula stage (RT-PCR)
|
|
|
|
S2 A
Reid CD et al. (2016)
|
Xla Wt + nodal1 + tle4
gastrula stage (RT-PCR)
|
|
|